1. Home
  2. MORN vs TECH Comparison

MORN vs TECH Comparison

Compare MORN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morningstar Inc.

MORN

Morningstar Inc.

HOLD

Current Price

$204.65

Market Cap

8.8B

Sector

Finance

ML Signal

HOLD

Logo Bio-Techne Corp

TECH

Bio-Techne Corp

HOLD

Current Price

$65.48

Market Cap

9.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MORN
TECH
Founded
1984
1976
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.2B
IPO Year
2005
1989

Fundamental Metrics

Financial Performance
Metric
MORN
TECH
Price
$204.65
$65.48
Analyst Decision
Strong Buy
Buy
Analyst Count
2
14
Target Price
$322.50
$70.46
AVG Volume (30 Days)
383.4K
2.1M
Earning Date
02-12-2026
02-04-2026
Dividend Yield
0.98%
0.47%
EPS Growth
16.18
N/A
EPS
8.80
0.49
Revenue
$2,395,400,000.00
$1,216,732,000.00
Revenue This Year
$8.92
$2.33
Revenue Next Year
$7.55
$6.89
P/E Ratio
$23.10
$140.18
Revenue Growth
7.76
3.85
52 Week Low
$199.97
$46.01
52 Week High
$335.21
$79.28

Technical Indicators

Market Signals
Indicator
MORN
TECH
Relative Strength Index (RSI) 40.64 50.90
Support Level $199.97 $66.94
Resistance Level $214.74 $68.54
Average True Range (ATR) 6.74 2.45
MACD -1.08 -0.22
Stochastic Oscillator 24.61 26.11

Price Performance

Historical Comparison
MORN
TECH

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Share on Social Networks: